Substituted triazole derivatives as oxytocin antagonists

Details Substituted triazole derivatives as oxytocin antagonists Substituted triazole derivatives as oxytocin antagonists

2006-03-08

2009-11-17

Wilson, James O (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S336000, C546S348000, C548S266200

Reexamination Certificate

active

07618972

ABSTRACT:
The present invention relates to a class of substituted triazoles of formula (I) with activity as oxytocin antagonists, uses thereof, processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction, particularly premature ejaculation (P.E.).

REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 2599000 (1952-06-01), Kerwin et al.
patent: 3381009 (1968-04-01), Palazzo et al.
patent: 3511836 (1970-05-01), Hans-Jurgen et al.
patent: 3527761 (1970-09-01), Archibald et al.
patent: 3997666 (1976-12-01), Witte et al.
patent: 4026894 (1977-05-01), Winn et al.
patent: 4188390 (1980-02-01), Campbell
patent: 4252721 (1981-02-01), Silvestrini et al.
patent: 4315007 (1982-02-01), Manoury
patent: 4703063 (1987-10-01), Imai et al.
patent: 5698560 (1997-12-01), Onoda et al.
patent: 5801180 (1998-09-01), Takase et al.
patent: 5861396 (1999-01-01), Niewohner et al.
patent: 5945117 (1999-08-01), El-Rashidy et al.
patent: 0526004 (1997-10-01), None
patent: 0995750 (1999-10-01), None
patent: 1092718 (2000-10-01), None
patent: 1092719 (2000-10-01), None
patent: 1097719 (2000-11-01), None
patent: 1293503 (2001-05-01), None
patent: WO9111172 (1991-08-01), None
patent: WO9312095 (1993-06-01), None
patent: WO9400453 (1994-01-01), None
patent: WO9492518 (1994-02-01), None
patent: WO9405661 (1994-03-01), None
patent: WO9415932 (1994-07-01), None
patent: WO9849166 (1998-11-01), None
patent: WO9902159 (1999-01-01), None
patent: WO9904433 (1999-01-01), None
patent: WO9954333 (1999-10-01), None
patent: WO0002550 (2000-01-01), None
patent: WO0024745 (2000-05-01), None
patent: WO0028993 (2000-05-01), None
patent: WO0035298 (2000-06-01), None
patent: WO0127112 (2001-04-01), None
patent: WO0127113 (2001-04-01), None
patent: WO0158880 (2001-08-01), None
patent: WO 2005/028452 (2005-03-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
Chawla, et al. Curr. Res. & Info. Pharm. Sci. (CRIPS), 5, 1, 2004, pp. 9-12.
Patani, et al. Chem. Rev., 96, 1996, pp. 3147-3176.
Arletti, et al.,Peptides, “Influence of oxytocin on feeding behavior in the rat.”, 10(1), 89-93, (1989).
Berman, et al.,Urology“Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options”, vol. 54(3), 385-91, (1999).
Finnin, et al.,Journal Pharm Science, ‘Transdermal Penetration Enhancers : Applications, Limitations, and potential’, vol. 88 (10), 955-958, (1999).
Gimpl, et al.,Physiological Reviews, “The oxytocin receptor system: structure, function, and regulation.” vol. 81(2), 629-683, (2001).
Leiblum S R,International Journal of Impotence Research, “Definition and classification of female sexual disorders” (1998), 10 Suppl 2 S104-6.
Liang, et al.,Expert Opinion in Therapeutic Patents, “Fast-dissolving intraoral drug deliver system”, vol. 11 (6), 981-986, (2001).
Melman, et al.,The Journal of Urology, “The epidemiology and pathophysiology of erectile dysfunction.” vol. 161(1), 5-11, (1999).
Nicholson, et al,Advances in Experimental Medicine and Biology, “Oxytocin and prostatic function.” vol. 395(Oxytocin), 529-538, (1995).
Rotella, et al.,Journal of Medicinal Chemistry, “N-3-Substituted Imidazoquinazolinones: Potent and Selective PDE5 Inhibitors as Potential Agents for Treatment of Erectile Dysfunction.” vol. 43(7), 1257-1263, (2000).
Truitt, et al..Science. “Identification of a potential ejaculation generator in the spinal cord.” vol. 297, 1566-1569, (2002).
Verma et al.,Pharmaceutical Technology On-line, Drug delivery technologies and future directions, vol. 25(2), 1-14,(2001).

Affiliated with

Also associated with

Rating

Substituted triazole derivatives as oxytocin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted triazole derivatives as oxytocin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted triazole derivatives as oxytocin antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4068380